Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical trials

Tools & Techniques Clinical trials

The SCOPE of Things to Come

It is your responsibility to encourage patients to join the SCOPE study

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Tools & Techniques Clinical trials

Trials, Interrupted

| Carl D. Regillo

Chief of the Retina Service at Wills Eye Hospital discusses the impact of COVID-19 on retina research

Tools & Techniques Clinical trials

A Framework for Translation

| Jonathan James

How strong partnerships can drive early-phase clinical trials

Tools & Techniques Cancer

Right for Patients?

| Ellen Sigal

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Tools & Techniques Drug discovery

What Women Want

| Stephanie Sutton

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Tools & Techniques Clinical trials

The Latest From the Cannabis Scientist

| Joanna Cummings

Talking at women in cannabis science, and meeting Raphael Mechoulam

Research Field Clinical trials

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Digital technologies could transform healthcare.

Tools & Techniques Clinical trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.

Tools & Techniques Drug discovery

Adopting an Orphan (Drug)

| Pan Pantziarka and Gauthier Bouche

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register